Abstract
Introduction: Neoadjuvant endocrine therapy (NAET) is increasingly being used in the management of oestrogen receptor positive (ER+) breast cancer (BC). Little is known about the rate of complete response, optimal method(s) for histological assessment of response to NAET, and the effect of the therapy on the histological characteristics and receptor status of the tumours. This study aims to assess the histological features of response to NAET and its effect on tumour type, grade and molecular profile.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
